Unknown

Dataset Information

0

Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).


ABSTRACT: BACKGROUND:Despite improved long-term safety of biodegradable polymer (BP) drug-eluting stents (DES) compared to first-generation durable polymer (DP) DES, data on the safety and efficacy of BP-DES compared with second-generation (2G) DP-DES in patients with acute myocardial infarction (AMI) are limited. HYPOTHESIS:To evaluate the safety and efficacy of BP-DES compared with 2G-DP-DES in the higher stent thrombosis (ST) risk setting of AMI. METHODS:A total of 3359 AMI patients who received either BP-DES (n = 261) or 2G-DP-DES (n = 3098) were included from the Korea Acute Myocardial Infarction Registry (KAMIR). Differences in baseline clinical and angiographic characteristics were adjusted using a 1:5 propensity score matching analysis (n = 261 for BP-DES and n = 1305 for 2G-DP-DES). The primary outcome was the incidence of major adverse cardiac events (MACE) including all-cause death, recurrent myocardial infarction (re-MI), and target vessel revascularization (TVR). The rate of definite or probable ST was also investigated. RESULTS:In adjusted analysis, there was no significant difference between the 2 groups in baseline clinical and angiographic characteristics; 2-year MACE (10.7% and 9.9% in the BP-DES group and 2G-DP-DES group, respectively, P = 0.679); ST incidence (0.8% vs 0.9%, respectively, P = 1.0), and rates of all-cause death, re-MI, and TVR. By multivariate analysis, old age, diabetes mellitus, renal dysfunction, and left ventricular dysfunction were the independent predictors of MACE after BP-DES or 2G-DP-DES implantation. CONCLUSIONS:BP-DES and 2G-DP-DES appear to have comparable 2-year safety and efficacy for the treatment of AMI. However, longer-term follow-up is needed.

SUBMITTER: Hur SH 

PROVIDER: S-EPMC6490733 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).

Hur Seung-Ho SH   Kim In-Cheol IC   Won Ki-Bum KB   Cho Yun-Kyeong YK   Yoon Hyuck-Jun HJ   Nam Chang-Wook CW   Kim Kwon-Bae KB   Kim Min-Seok MS   Park Jincheol J   Rha Seung-Woon SW   Chae Shung-Chull SC   Kim Young-Jo YJ   Kim Chong-Jin CJ   Cho Myeong-Chan MC   Jeong Myung-Ho MH   Ahn Young-Keun YK   Kim Hyo-Soo HS   Ahn Tae-Hoon TH   Seung Ki-Bae KB   Jang Yangsoo Y   Yoon Jung-Han JH   Seong In-Whan IW   Hong Taek-Jong TJ   Bae Jang-Ho JH   Park Seung-Jung SJ  

Clinical cardiology 20160330 5


<h4>Background</h4>Despite improved long-term safety of biodegradable polymer (BP) drug-eluting stents (DES) compared to first-generation durable polymer (DP) DES, data on the safety and efficacy of BP-DES compared with second-generation (2G) DP-DES in patients with acute myocardial infarction (AMI) are limited.<h4>Hypothesis</h4>To evaluate the safety and efficacy of BP-DES compared with 2G-DP-DES in the higher stent thrombosis (ST) risk setting of AMI.<h4>Methods</h4>A total of 3359 AMI patien  ...[more]

Similar Datasets

| S-EPMC7552849 | biostudies-literature